Anti-obesity effects of resveratrol: comparison between animal models and humans. (Q39040883)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

title

Anti-obesity effects of resveratrol: comparison between animal models and humans (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Iñaki Milton-Laskibar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

author name string

Alfredo Fernández-Quintela

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Christian Carpéné

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Maialen Fernández

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

José Contreras

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Maria P Portillo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

publication date

1 August 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

Journal of Physiology and Biochemistry

30 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

page(s)

417-429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13105-016-0544-y

30 March 2020

exact match

0 references

cites work

Resveratrol: anti-obesity mechanisms of action.

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Resveratrol does not increase body fat loss induced by energy restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Changes in white adipose tissue metabolism induced by resveratrol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Thermogenesis is involved in the body-fat lowering effects of resveratrol in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Plant foods and herbal sources of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Resveratrol exerts anti-obesity effects in high-fat diet obese mice and displays differential dosage effects on cytotoxicity, differentiation, and lipolysis in 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Pilot study of resveratrol in older adults with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Oral Resveratrol Prevents Osteoarthritis Progression in C57BL/6J Mice Fed a High-Fat Diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

The obesity epidemic, metabolic syndrome and future prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Antiobesity and vasoprotective effects of resveratrol in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Food components with anti-obesity effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Phytochemicals and their impact on adipose tissue inflammation and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Distinct metabolic effects of resveratrol on lipogenesis markers in mice adipose tissue treated with high-polyunsaturated fat and high-protein diets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Effects of resveratrol on changes induced by high-fat feeding on clock genes in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Effect of dietary resveratrol on the metabolic profile of nutrients in obese OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

ε-Viniferin, a resveratrol dimer, prevents diet-induced obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Dose translation from animal to human studies revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Resveratrol, obesity and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Distinct effects of calorie restriction and resveratrol on diet-induced obesity and Fatty liver formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Identification of Mest/Peg1 gene expression as a predictive biomarker of adipose tissue expansion sensitive to dietary anti-obesity interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-016-0544-Y

Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27981508

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27981508

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The combination of resveratrol and quercetin enhances the individual effects of these molecules on triacylglycerol metabolism in white adipose tissue

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27981508

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13105-016-0544-Y

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981508%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

1 reference